Therefore, it is wise to investigate the lack/presence of sortilin in patients with MCL and MZL; which may add another tumor marker to the current diagnostic panel for differentiating CLL from other Non-Hodgkin’s lymphomas. Here, SORT1 is linked to non-Hodgkin lymphoma.